Registration: https://thinkin.fr/products/the-injectable-summit/attend/
THE VERY FIRST SUMMIT GATHERING THREE SECTORS
Academics, clinicians, and industry executives dedicated to aesthetic injectables together in one setting? The Medical Aesthetic Injectable Summit (MAIS) is the very first event to accomplish such a feat.
From KOL physicians and academic researchers to C-suite executives and startups, all leaders in the field are gathering to delve into the latest research, market analysis, upcoming trends, disruptive innovations, AI applications, and more, to understand and challenge the future of injectables in skin health.
The Summit is a practical opportunity for you to develop your scientific and business knowledge in just two days.
Continue reading to see the program details!
EARLY BIRD ENDING SOON
BE PART OF THE MUST-ATTEND SUMMIT NEVER BEFORE SEEN IN OUR FIELD
|
Wednesday, July 31 is the LAST CHANCE to register to the Medical Aesthetic Injectable Summit (MAIS) with Early Bird rates.
|
$800 USD
$1,300 USD after July 31, 2024
|
MEET THE SPEAKERS |
The Summit is led by renowned physicians, scientific researchers, industry executives, top market analysts, and various experts from around the world.
| | |
|
|
David Amsellem Industry Analyst, USA
Pierre Andre Dermatologist, France
Rui Avelar Head of R&D and CMO, Evolus, USA
Abraham Benzaquen Dermatologist, Spain
Alexandre Brennan CEO, Fillmed., France
Pascal Bordat CSO, Kylys, Swizterland
Vin Bucci Industry Consultant, USA
Benoit Chardon CCO, Allurion, United Kingdom
Michel Cheron CEO, Laboratoires Vivacy, France
Denis Couchourel Scientific & Mktg Director, Vivacy, France
Daniel De Boer Executive VP BD & Strategy, Croma, Switzerland
Dirk Dressler PhD, Germany
Haim Dvir Founder & CEO, E.N.A. Impeccable Skincare Solution, Israel
Shimon Eckhouse Chairman, Alon Medtech Ventures, Israel
Jon Edelson CEO & President, Eirion Therapeutics, USA
Mutlu Erturan CEO, The Mage Group, UK
Yoram Eshel CEO, Kolorpen, Israel
Ferial Fanian Scientific Director, Laboratoires Fillmed, France
Francois Fournier CEO, HTL Biotechnology, France
Mary Gardner CEO & Founder, Delnova, USA
Anne Laure Gaudry Head of Innovation, R&D, HTL, France
Vincent Hunsinger Plastic Surgeon, France
Rong Sheng Jin PhD, USA
Anna Kadzhaya Head of Scientific & Clinical Dev., Aptos, Georgia
|
Ario Khoshbin President & CEO, Prollenium, Canada
Tim Lugo Industry Analyst, William Blair, USA
Stephane Meunier CEO, Hallura, Israel
David Moatazedi President & CEO, Evolus, USA
Hyoung Jin Moon Rep. Executive Officer, Hugel, South Korea
Miguel Pardos CEO, Sinclair, Spain
Marco Pirazzini PhD, Italy
Rainer Pooth MD, Germany
Alexandre Porcello Managing Partner, Kylys Aesthetics, Switzerland
Andreas Prinz Managing Director, Croma Pharma, Austria
Laura Reviellon Industry Analyst, BCG, France
Monica Rocha Dir. Clinical & Medical Affairs, Aqpha, Netherlands
Chiara Schiraldi PhD, Italy
Komal Ayah Siddiqi Aesthetic Doctor & Clinical Scientist, UK
Luca Stucchi CSO, BMG Pharma, Italy
George Sulamanidze CEO, Aptos, Georgia
Piero Tabarani Industry Consultant, Arazy Group, Canada
Raghav Tangri Industry Analyst, Cetas Healthcare, India
Tunc Tiryaki CMO, The Mage Group, UK
Karl Waked CMO, Augmented Anatomy, Belgium
Jennifer L Walden Plastic Surgeon, USA
Michael Yu PhD, USA
Zhang Qing Industry Consultant, Beijing Reg-med, China
|
|
SESSION FORMATS |
The two days cover the entire ecosystem around injectables.
Day 1 focuses on Neuromodulators while Day 2 explores Dermal fillers.
|
|
|
